谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV plus P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

T. B. Powles,B. Perez Valderrama,S. Gupta,J. Bedke,E. Kikuchi,J. Hoffman-Censits,G. Iyer,C. Vulsteke,S. H. Park,S. J. Shin,D. E. Castellano Gauna,G. Fornarini,J-R. Li,M. Gumus,N. Mar, S. Narayanan, X. Yu, S. Gorla, B. M. S. Homet Moreno van der Heijden

ANNALS OF ONCOLOGY（2023）

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要